50-5-251: Health freedom and access requirement.

(1) A licensed experimental treatment center shall allocate 2% of its net annual profits to support access to experimental treatments and health care for qualifying Montana residents. This allocation must be documented on a form provided by the department and submitted by February 1 of each year.

(2) The health freedom and access requirement prescribed in subsection (1) may be fulfilled by:

(a) providing free experimental treatment, as that term is defined in 50-12-102, to qualifying Montana residents in an amount that is equal to at least 2% of the center's net annual profits; or

(b) contributing 2% of the center's net annual profits into the insurance premium support account established in 50-5-252.

(3) The department shall develop policies and procedures, including application and reimbursement processes, to:

(a) determine who are qualifying Montana residents for the purpose of implementing this section; and

(b) support requests by Montana residents for the provision of experimental treatments at experimental treatment centers under this section.